MAIA Biotechnology (MAIA) Stock: Buy, Sell, or Hold?
MAIA - MAIA Biotechnology, Inc.
$1.36
0.05 (4.23%)
â˛
5d:
+2.65%
30d:
+1.12%
90d:
+4.23%
WAIT
LOW Confidence
Analysis Updated: Sep 14, 2026 12:00 AM ET
Earnings: Aug 10, 2026
0d
Get Alerted When MAIA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: MAIA is fairly priced but lacks strong directional signals. At 7.9% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: MAIA is fairly priced but lacks strong directional signals. At 7.9% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$1.40
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$0.87
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 0.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: MAIA is currently trading at $1.35, which is considered fair relative to its 30-day fair value range of $1.32 to $1.40. From a valuation perspective, the stock is trading at a premium (Forward PE: 1.2) compared to its historical average (0.9). At these levels, the market is pricing in 7.9% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, MAIA is in a strong downtrend. Immediate support is located at $1.27, while resistance sits at $1.46. The stock is showing strong short-term momentum, up 4.2% recently.
Market Sentiment: MAIA scores 27/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $12.00 (+823.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MAIA is in a strong downtrend. Immediate support is located at $1.27, while resistance sits at $1.46. The stock is showing strong short-term momentum, up 4.2% recently.
Market Sentiment: MAIA scores 27/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $12.00 (+823.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.32 -
$1.40
Company Quality Score
35/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
53.8%
All Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (27/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.2%)
- BULLISH: Trading 823.1% below Wall St target ($12.00)
- NEUTRAL: Trading at premium valuation - market expects 7.9% growth which is achievable
- WARNING: Composite score 35/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.32 -
$1.40
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$1.27
Resistance Level
$1.46
Current Trend
Strong Downtrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
1.17
Wall Street Target
$12.00
(+823.1%)
Valuation Premium vs History
+7.9% premium
PE vs Historical
1.2 vs 0.9
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+7.9%
(market-implied from PE analysis)
1-Year Target
$1.40
(+8%)
2-Year Target
$1.51
(+16%)
3-Year Target
$1.63
(+26%)
3-Yr Target (if PE normalizes)
(PE: 1â1)
PE COMPRESSION
$1.25
(-4%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: September 14, 2026 1:23 PM ET
Data refreshes hourly during market hours. Next update: 2:23 PM
Data refreshes hourly during market hours. Next update: 2:23 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MAIA showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 34 SELL |
|
REGN
Regeneron PharmaceuticalâĻ |
STRONG BUY
25 analysts |
$849 | 50 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$290 | 55 HOLD |
|
MLTX
MoonLake ImmunotherapeutâĻ |
STRONG BUY
16 analysts |
$29 | 41 HOLD |
|
ACAD
ACADIA Pharmaceuticals IâĻ |
BUY
20 analysts |
$34 | 55 HOLD |
